Given the following molecule represented by the SMILES string: Cc1nnc(SCC(=O)NCC2CCCCC2)n(N)c1=O, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Step 1: The given SMILES string represents a complex molecule that includes a pyrrole ring, a thiazole ring, and a quinoline-like structure. This structure suggests the molecule could be an inhibitor or modulator of enzymes or receptors involved in signal transduction pathways.
Step 2: The presence of a thiazole ring and a quinoline-like structure is indicative of potential interactions with enzymes such as cytochrome P450s (CYP enzymes), which are known to metabolize a wide range of drugs and xenobiotics. This is particularly relevant for CYP1A2, CYP2C19, CYP2C9, and CYP2D6, which are all listed among the provided genes.
Step 3: The molecule also has a quinoline-like structure, which might interact with G protein-coupled receptors (GPCRs). Specifically, this could relate to adrenergic receptors (ADRA1D, ADRA2B, ADRB2) and muscarinic acetylcholine receptors (CHRM1, CHRM3, CHRM4).
Step 4: Additionally, the moleculeâ€™s structure may have implications for other receptors and enzymes listed, such as dopamine receptors (DRD2, DRD3, DRD4) and serotonin receptors (HTR1A, HTR2A, HTR2B, HTR2C, HTR6), which are known to have diverse ligands and inhibitors.
Step 5: Given the structure and functional groups present, the most likely related genes are those involved in drug metabolism (CYP1A2, CYP2C19, CYP2C9, CYP2D6) and neurotransmission (ADRA1D, ADRA2B, ADRB2, CHRM1, CHRM3, CHRM4, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6).
Summary of related genes: CYP1A2, CYP2C19, CYP2C9, CYP2D6, ADRA1D, ADRA2B, ADRB2, CHRM1, CHRM3, CHRM4, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6.
